Sativa Wellness Group expect a significant ramp up (Interview)

Sativa Wellness Group Inc. (AQSE:SWEL / CNSX:SWEL) Executive Chairman Germey Thomas joins DirectorsTalk Interviews to discuss reaching its £1m milestone for COVID testing. Geremy talks us through the milestone, the addition of further testing clinics including two mobile units, the significance of having 30 clinics to the company and how long Geremy thinks the PCR testing revenue stream will last.

Sativa Wellness Group goal is to build Europe’s leading CBD Wellness brands, to meet today’s fast evolving consumer expectations. Through full vertical integration of their supply chain, they plan to become one of the premier low-cost producers and high-quality distributors of CBD wellness products in Europe.

Find more news, interviews, share price & company profile here for:
Goodbody Health

Share this interview

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on whatsapp
Sativa Wellness Group expect a significant ramp up (Interview)

Other Interviews

More News

Ask your questions

Do you have questions you’d like to ask this company, get in touch and we’ll ask them for you.   

I have questions